BIOCRYST PHARMACEUTICALS, INC. / MAX COOPER

Company

BIOCRYST PHARMACEUTICALS INC

Filed

July 16, 1999

Accession Number

0000950144-99-008932

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →